WHO multicentre randomised trial of misoprostol in the management of the third stage of labour.

Background: Postpartum haemorrhage is a leading cause of maternal morbidity and mortality. Active management of the third stage of labour, including use of a uterotonic agent, has been shown to reduce blood loss. Misoprostol (a prostaglandin E1 analogue) has been suggested for this purpose because i...

Descripción completa

Detalles Bibliográficos

Publicado en:	Lancet Vol. 358; no. 9283; pp. 689 - 696
Autores principales:	Gülmezoglu AM, Villar J, Ngoc NTN, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr GJ, Lumbiganon P, Unger C, Prendiville W, Pinol A, Elbourne D, El-Refaey H, Schulz KF, Gülmezoglu, A M, Villar, J, Ngoc, N T, Piaggio, G
Formato:	clinical trial research tables/charts Journal Article
Publicado:	Lancet 9/1/2001
Acceso en línea:	Ver este registro en EBSCOhost